Liver Cancer Summit 2022
The scientific programme of the three-day Liver Cancer Summit 2022 will provide delegates with a live experience dedicated entirely to primary liver cancers. International experts will deliver up-to-date talks on basic, translational, and clinical studies on hepatocellular carcinoma (HCC), cholangiocarcinoma (CCA), and rare primary liver cancers.
The format will combine state-of-the-art educational lectures and lively debates, with numerous occasions to interact with the experts. Because the boundaries are currently moving fast, global approaches will be highlighted, whether this directly affects HCC and CCA in basic aspects, global epidemiology of liver tumours or treatment combination strategies.
Who should attend the summit
- clinicians and scientists, basic and clinical, from all fields related to liver cancer
- investigators, physicians, surgeons, radiologists, biologists
- nurses and allied health professionals
- patient organisations
- members of the biotech and pharmaceutical industries
Health & Safety
All face-to-face EASL events follow the latest in health and safety measures. Your safety is our priority. We are merging the very best of face-to-face events with cutting-edge developments in meeting technology. With more time for reflection, more space for comfort.
All session rooms, catering points, exhibition areas, and corridors will be arranged to keep delegates at a safe, yet friendly distance. You can once again enjoy mingling again with your peers, connecting nationally and internationally, across the full liver community.
We look forward to meeting again with you in a stimulating and secure setting.